Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 5350 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d568-c457-76c3-bd96-6befca91af73

adms:identifier	mi-legislature-measure 2023-2024/HB/5350
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Alabas Farhat
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5350 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5350 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5350 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5350
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	HB 5350
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211 ) by adding sec. 17757c.en
schema:sponsor	Alabas Farhat Karen Whitsett Helena Scott Donavan McKinney Erin Byrnes Reggie Miller Jimmie Wilson Jr Carrie Rheingans Jennifer Conlin Brenda Carter Jasper Martus Cynthia Neeley Penelope Tsernoglou Emily Dievendorf Gina Johnsen Phil Skaggs Carol Glanville Jim Haadsma Rachel Hood
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5350
skos:prefLabel	HB 5350 (2023-2024)en
status	in committee
status date	2024-01-10xsd:date